P F A Mulders - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P F A Mulders

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Nederlands Tijdschrift Voor Geneeskunde|April 3, 2008

[Guideline 'Renal cell carcinoma']P F A Mulders, A H Brouwers, C A Hulsbergen-van der Kaa, et al.

Prostate Cancer and Prostatic Diseases|October 2, 2013

Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancerO B Goodman, T W Flaig, A Molina, et al.

British Journal of Cancer|March 5, 2004

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patientsI Bleumer, A Knuth, E Oosterwijk, et al.

European Urology|August 2, 2005

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark projectM P M Q van Gils, U H Stenman, J A Schalken, et al.

Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 17, 2012

Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot studyI M E Desar, E G W ter Voert, Th Hambrock, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 3, 2008

[Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus]P H M de Mulder, J B A G Haanen, S Sleijfer, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Nederlands Tijdschrift Voor Geneeskunde|April 3, 2008

[Guideline 'Renal cell carcinoma']P F A Mulders, A H Brouwers, C A Hulsbergen-van der Kaa, et al.

Prostate Cancer and Prostatic Diseases|October 2, 2013

Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancerO B Goodman, T W Flaig, A Molina, et al.

British Journal of Cancer|March 5, 2004

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patientsI Bleumer, A Knuth, E Oosterwijk, et al.

European Urology|August 2, 2005

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark projectM P M Q van Gils, U H Stenman, J A Schalken, et al.

Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 17, 2012

Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot studyI M E Desar, E G W ter Voert, Th Hambrock, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 3, 2008

[Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus]P H M de Mulder, J B A G Haanen, S Sleijfer, et al.

Pageof 2